February 17, 2018 5:04 PM ET


Company Overview of Xellia Pharmaceuticals ApS

Company Overview

Xellia Pharmaceuticals ApS, a specialty pharmaceutical company, engages in the development, manufacture, and supply of anti-infective products, including fermented and semi-synthetic active pharmaceutical ingredients, and finished dosage forms for pharmaceutical companies worldwide. It offers a range of antibiotic contract manufacturing services, from custom synthesis of clinical trial material through to large scale manufacturing of marketed products, as well as stability testing, filling, and packaging services for dry powder filled vials and lyophilized/freeze-dried vials. The company was formerly known as Alpharma Aps. Xellia Pharmaceuticals ApS was incorporated in 1959 and is based in C...

Dalslandsgade 11

Copenhagen S

Copenhagen,  2300


Founded in 1959


45 32 64 55 00


45 32 64 55 01

Key Executives for Xellia Pharmaceuticals ApS

Chief Executive Officer and President
Age: 54
Chief Financial Officer and Vice President of Finance
Age: 60
Chief Legal Officer and Vice President
Vice President of Human Resources
Vice President of Regulatory Affairs
Compensation as of Fiscal Year 2017.

Xellia Pharmaceuticals ApS Key Developments

Xellia Pharmaceuticals Expands Budapest Plant in Kabanya

Xellia Pharmaceuticals has expanded its Budapest plant with a new building, the 13 million dollar investment will create 80 new, highly qualified workplaces at the facility in Kabanya. The 3,000 square metre building, which will house the company groups global laboratory services centre.

Xellia Pharmaceuticals Announces to Expand Budapest-Based Unit for USD 10 Million

Xellia Pharmaceuticals announced that it has laid the cornerstone for a new 3,000 sqm building for its Budapest-based factory. The investment will cost USD 10 million. The new facility, scheduled to be completed by summer 2017, will house microbiology and chemical analysis laboratories as well as offices. The company is expected to increase its current headcount of 200 by 80 as a result of the investment.

Similar Private Companies By Industry

Company Name Region
7TM Pharma A/S Europe
Acesion Pharma ApS Europe
Action Pharma A/S Europe
Adenium Biotech ApS Europe
Alkalon A/S Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xellia Pharmaceuticals ApS, please visit www.xellia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.